Internal Medicine, Cardiovascular Disease · Saratoga Springs, NY
NPI
1508834540
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
6 Care Lane
Saratoga Springs, NY, 12866
Phone (518) 587-7625
Groups this clinician bills Medicare through
Medicare paid, 2024
$847K
29,184 services
Medicare patients, 2024
900
Average age 75
Drug cost, 2024
$2.5M
11,704 prescriptions
Company payments, 2025
$601
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas Kondo was code J1306 (injection, inclisiran, 1 mg), 21,016 times for 39 patients. In total Nicholas Kondo billed 29,184 services in 85 codes, and Medicare paid $847K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 21,016 | 39 | $9.51 | $200K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,193 | 609 | $11.62 | $14K |
| 93000 Electrocardiogram | Office | 1,097 | 624 | $9.80 | $11K |
| 99214 Office E&M - Established | Office | 1,087 | 564 | $87.09 | $95K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 620 | 155 | $4.80 | $2,976 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 351 | 118 | $46.68 | $16K |
| 99457 E&M - Miscellaneous | Office | 317 | 113 | $36.52 | $12K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 280 | 140 | $414.62 | $116K |
| 93306 Echocardiography (TTE/TEE) | Office | 225 | 200 | $129.12 | $29K |
| 99454 E&M - Miscellaneous | Office | 217 | 101 | $34.79 | $7,549 |
| 93296 External Electrocardiographic Monitoring | Office | 211 | 61 | $13.99 | $2,953 |
| 93015 Electrocardiogram | Office | 205 | 202 | $50.02 | $10K |
| 93294 External Electrocardiographic Monitoring | Office | 155 | 45 | $19.24 | $2,983 |
| 78431 Myocardial Perfusion Scan | Office | 140 | 140 | $1,241.53 | $174K |
| 78434 Myocardial Perfusion Scan | Office | 140 | 140 | $99.65 | $14K |
By year: 2022 $155K for 2,662 services; 2023 $589K for 14,685 services; 2024 $847K for 29,184 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 117 | 100 | $8.65 | $1,012 |
| 80053 Clinical Chemistry | 80 | 75 | $10.35 | $828 |
| 80061 Clinical Chemistry | 68 | 64 | $12.93 | $879 |
| 85025 Blood Count | 65 | 61 | $7.49 | $487 |
| 83880 Clinical Chemistry | 61 | 55 | $37.84 | $2,308 |
| 83735 Clinical Chemistry | 53 | 51 | $6.57 | $348 |
| 84484 Clinical Chemistry | 46 | 46 | $11.95 | $550 |
| 84443 Clinical Chemistry | 35 | 35 | $16.46 | $576 |
| 84439 Clinical Chemistry | 26 | 26 | $8.84 | $230 |
| 80048 Clinical Chemistry | 20 | 18 | $7.88 | $158 |
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas Kondo prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,698 prescriptions and refills. In total Nicholas Kondo wrote 11,704 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,698 | 4,822 | 529 | $35K |
| Atenolol Generic | 908 | 2,599 | 282 | $7,171 |
| Ezetimibe Generic | 901 | 2,626 | 285 | $36K |
| Eliquis Apixaban | 716 | 1,760 | 201 | $1.0M |
| Olmesartan Medoxomil Generic | 658 | 1,873 | 207 | $22K |
| Atorvastatin Calcium Generic | 583 | 1,686 | 186 | $8,888 |
| Torsemide Generic | 457 | 1,201 | 156 | $7,218 |
| Metoprolol Succinate Generic | 396 | 1,126 | 133 | $5,450 |
| Nifedipine Er Nifedipine | 393 | 1,105 | 124 | $9,295 |
| Losartan Potassium Generic | 382 | 1,082 | 126 | $2,898 |
| Lisinopril Generic | 312 | 868 | 97 | $1,611 |
| Repatha Sureclick Evolocumab | 282 | 628 | 73 | $356K |
| Carvedilol Generic | 239 | 661 | 75 | $2,155 |
| Clopidogrel Clopidogrel Bisulfate | 225 | 604 | 70 | $2,683 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 212 | 600 | 71 | $11K |
Brand drugs: 1,810 claims; generic drugs: 9,894 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas Kondo $601 ($601 in general payments such as food, travel and fees) from 16 companies. The largest payer was Merck Sharp & Dohme LLC with $101.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 6 | $101 |
| Pfizer Inc. PFE | 4 | $74.87 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $63.57 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $54.81 |
| BridgeBio Pharma, Inc. BBIO | 3 | $50.87 |
| Amgen Inc. AMGN | 3 | $43.73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43.66 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $32.02 |
| Philips North America LLC PHG | 1 | $26.64 |
| Chiesi USA, Inc. | 1 | $19.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.